Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Patrick who wrote (1440)	3/24/1998 12:48:00 AM
From: Dugman	Read Replies (3) \| Respond to of 8117

How about Abbott Labs in Austin Texas. They are (or were a few years back) the largest makers of I.V. bags in the known universe. I'm not sure if they got bought out or merged with someone a little while back. They've got the network and the facilities to make it happen. Someone forward this to PYNG's people.

To: Patrick who wrote (1440)	3/24/1998 6:58:00 AM
From: Justin Curran	Respond to of 8117

Patrick, excellent post. Information heavy posts like that are exactly what makes S.I. such an indespensible tool. All contributors draw on each others experiences/knowledge to create a greater whole. In your opinion is it too early in the lifetime of this company for any large S&D corperation to become interested in a partial partnership in exchange for exclusive disribution? In your experience how far down the line do these partnerships usually materialize? That was a strong close we had yesterday after a rough open. Hopefully that strength will continue into this morning. Once again, good luck to all PYT shareholders. Justin Curran.

To: Patrick who wrote (1440)	3/24/1998 7:37:00 AM
From: G.F.	Read Replies (2) \| Respond to of 8117

You have made some very important and very astute observations in your description of what your perception of the future of this stock is..You certainly make some vey valid points..I think the future bodes very well for all of us that sit tight and watch this thing unfold before our eyes..Mr Jacobs and his team I beleive will do what is best for all concerned..He obviously has a very large stake himself in this thing so I suspect that as far as the manufacturing and production and distribution I suspect he is exploring all the options that are available to him..He has been very methodical in his march to see this thing thru to fruition and I beleive that hes gone too far too turn back now and that even bigger and better things lie ahead..Inevitably i would think that a buyout is in order down the road but I think that the way that he is introducing it to the medical world thru field trials will only make them salivate if the desired results are reached and when actual sales start I think you,re going to have them falling all over themselves to have the product on hand..I think the fact that 22 more organizations have submiited their name to be the site of a feild test site or to be placed on the list of names offering to use the product is just a sign of whats ahead..the international conference this week should open more eyes..With the potential that this stock has to move to the upside from here on out I would think that shorting it too much is a very dangerous game to play and somewhere someday the shorts are going to get caught "BIGTIME"..oh well..thats what makes investing and trading so interesting..the end of the month is rapidly approaching so we should except to see some scrambling to cover short positions..look for the price to move up.again..excellent post you made..Good Luck..Happy Investing..Yes!..the best is yet to come.

To: Patrick who wrote (1440)	3/24/1998 12:59:00 PM
From: Bernard Elbaum	Respond to of 8117

M. Jacobs did post on this thread in Dec. or Jan. as I remember that he was in contact with larger firms that could be potential collaborators with Pyng. If you find one of his more recent posts, and search his personal profile, you should find the post in question. There is no question that Pyng, with its currently tiny organization, would benefit from a joint arrangement with a big firm that has marketing and distribution clout. Pyng does potentially have an unusual ace in the hole, however--the FAST1 is desiged to be a backup procedure in emergency life or death cases where there are no good alternatives. If the fieldwork trials give the FAST1 a sufficiently favorable review, experts in emergency medicine may go so far as to recommend it as a standard backup procedureto the IV. Providers who lack the FAST1 may then be liable to lawsuit. To clear up some confusion, if you read the PYNG web site, you should understand that the FAST1 will have no sizable impact on the market share of IV devices. The FAST1 is designed for the estimated 500,000 cases per year in the US where patients are taken by ambulance without an IV because it proved too difficult to administer.

To: Patrick who wrote (1440)	3/24/1998 2:46:00 PM
From: Geoff Krone	Respond to of 8117

Patrick, your Post #1440 was among the best and most constructive contributions I've seen on many a thread. I have been following Pyng since last Summer, finally bought a few shares at just under $3.00 (Cdn.), and am extremely positive about the company. (I confess to being a "30-Day Wonder" on SI, but I trust that won't be held against me, as I'm not here for the purpose of attempting to influence the market.) Others have talked about production as a potential bottleneck, and you focused your comments on distribution as a potential bottleneck. Some folks have presented interesting counterarguments: production may not be that difficult, and distribution may not be a problem if the world is literally beating a path to your door. I am wondering whether the most significant bottleneck might be neither production nor distribution, but training. Clearly, it does not take extensive training to use the F.A.S.T.1, but in this field the potential liability is far too great to take any risk whatsoever that a completely unexpected event might occur. If someone dies because the caregiver was not properly trained to use the device, it's all she wrote. It will be essential to define what constitutes adequate training, and if that means more than just watching a videotape, then certification of proper training will (IMO) be the tightest bottleneck. Consequently, the most important contribution that an ally could make to Pyng may be by providing a network of qualified trainers. Will Mr. Jacobs decide to cut anyone in on the pie? I personally don't think he would have to, because Pyng could gradually ramp up production and build distribution channels of their own. I think it would just take an extra year or two. But even though he wouldn't have to, I believe that he will, because he appears to be an ethical person. Because this truly is a lifesaving device, people will die unnecessarily, if its availability is unnecessarily delayed. I think Mr. Jacobs will be more than willing to sacrifice a few percent of the fortune he stands to make, in order to save a few hundred more lives by getting it into the hands of EMS personnel a year or two quicker. An intermediate solution might be to enter into a contractual arrangement with a company whose role would be limited to the provision of training. With that bottleneck removed, then Pyng could consider whether they need help with production and/or distribution. Best regards, and thanks to all who have made the SI Pyng thread such a great place to lurk! Geoff